REGN Exercise Disclosure
Sing George L · SEC Form 4 · Filed Nov 4, 2026
Exercise
Calculated transaction value
$0
Sing George L Director
REGN
Transaction date
Nov 2, 2026
Public filing date
Nov 4, 2026
Filing lag
Filed 2 days later
REGN daily price context
Close on/before transaction
$961.26
Nov 2, 2026
First close after public filing
--
Unavailable
30-day return after filing
--
Through Unavailable
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Non-Qualified Stock Option (right to buy) on Common Stock
- Quantity / price
- 7,439 shares @ $0
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001225471-26-000004
Filing cohort
Transactions in this filing
Showing 13 of 13
Trades
13
Issuers
1
Estimated value
$26.16M
Buys / sales
0 / 9
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Regeneron Pharmaceuticals, Inc. REGN | Sale | Nov 2, 2026 | $4.18M |
| Regeneron Pharmaceuticals, Inc. REGN | Sale | Nov 2, 2026 | $2.58M |
| Regeneron Pharmaceuticals, Inc. REGN | Sale | Nov 2, 2026 | $6.83M |
| Regeneron Pharmaceuticals, Inc. REGN | Exercise | Nov 2, 2026 | $0 |
| Regeneron Pharmaceuticals, Inc. REGN | Sale | Nov 2, 2026 | $1.18M |
| Regeneron Pharmaceuticals, Inc. REGN | Exercise | Nov 2, 2026 | $2.95M |
| Regeneron Pharmaceuticals, Inc. REGN | Sale | Nov 2, 2026 | $1.01M |
| Regeneron Pharmaceuticals, Inc. REGN | Sale | Nov 2, 2026 | $194.04K |
| Regeneron Pharmaceuticals, Inc. REGN Current | Exercise | Nov 2, 2026 | $0 |
| Regeneron Pharmaceuticals, Inc. REGN | Exercise | Nov 2, 2026 | $2.83M |
| Regeneron Pharmaceuticals, Inc. REGN | Sale | Nov 2, 2026 | $519.4K |
| Regeneron Pharmaceuticals, Inc. REGN | Sale | Nov 2, 2026 | $2.43M |
| Regeneron Pharmaceuticals, Inc. REGN | Sale | Nov 2, 2026 | $1.47M |